You have no items in your shopping cart.
You have no items in your shopping cart.
Catalog Number | orb1739273 |
---|---|
Category | Small Molecules |
Description | Pimodivir tosylate |
Purity | 98.00% |
MW | 571.6 |
Biological Activity | Pimodivir, also known as VX-787, JNJ-872, is a novel inhibitor of influenza virus replication that blocks the PB2 cap-snatching activity of the influenza viral polymerase complex. VX-787 binds the cap-binding domain of the PB2 subunit with a KD (dissociation constant) of 24 nM as determined by isothermal titration calorimetry (ITC). The cell-based EC50 (the concentration of compound that ensures 50% cell viability of an uninfected control) for VX-787 is 1.6 nM in a cytopathic effect (CPE) assay, with a similar EC50 in a viral RNA replication assay. VX-787 is active against a diverse panel of influenza A virus strains, including H1N1pdm09 and H5N1 strains, as well as strains with reduced susceptibility to neuraminidase inhibitors (NAIs). |
CAS Number | 1777814-27-3 |
Formula | C27H27F2N5O5S |
SMILES | Cc1ccc(cc1)S(O)(=O)=O.OC(=O)[C@H]1C2CCC(CC2)[C@@H]1Nc1nc(ncc1F)-c1c[nH]c2ncc(F)cc12 |
Storage | -20°C |
Note | For research use only |